The AMRF is currently committed to funding research that meets the following criteria:
* investigating potential treatments for advanced melanoma that are:
* related to the human immune system (immunotherapy)
* low cost
* low toxicity
* for all patients
Current Sponsored Research Projects
1) Analysis of the recently completed EMOTIV Melanoma Vaccine Study.
2) Immune Cycle Mathematical Analysis - a collaboration between faculties of the University of Adelaide that is delving into proposed cyclical behaviours of the human immune system.
3) Long Term Survival Analysis - ongoing surveillance/analysis of the survivors of the 2000-2010 VMCL trial.
4) Timing Effect of IL-2 Therapy of Melanoma in a Mouse Model (completed - awaiting publication)
5) Timing Effect of Higher Dose IL-2 Therapy of Melanoma in a Mouse Model (completed - undergoing statistical analysis)
Adelaide Melanoma March 2019 in conjunction with Melanoma Institute Australia.
All net proceeds raised through this year’s Melanoma March will support a national collaborative research project that will allow researchers and clinicians to personalise immunotherapies for patients – in essence, to match the treatment provided to the patient with the tumour of that patient. It will be known as the Personalised Immunotherapy Project and this will be a great stride towards our mission of zero deaths from melanoma.